Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants
The Journal of Clinical Pharmacology · 2024
DOI: 10.1002/jcph.2434 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Sean McCann und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel H…. Hauptthemen laut MEDLINE: Dexmedetomidine, Hypnotics and Sedatives, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Pharmacokinetics/Pharmacodynamics Fellowship, University of North Carolina.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Dexmedetomidine is a sedative used in both adults and off‐label in children with considerable reported pharmacokinetic (PK) interindividual variability affecting drug exposure across populations. Several published models describe the population PKs of dexmedetomidine in neonates, infants, children, and adolescents, though very few have been externally evaluated. A prospective PK dataset of dexmedetomidine plasma concentrations in children and young adults aged 0.01‐19.9 years was collected as part of a multicenter opportunistic PK study. A PubMed search of studies reporting dexmedetomidine PK identified five population PK models developed with data from demographically similar children that were selected for external validation. A total of 168 plasma concentrations from 102 children were compared with both population (PRED) and individualized (IPRED) predicted values from each of the five published models by quantitative and visual analyses using NONMEM (v7.3) and R (v4.1.3). Mean percent prediction errors from observed values ranged from −1% to 120% for PRED, and −24% to 60% for IPRED. The model by James et al, which was developed using similar “real‐world” data, nearly met the generalizability criteria from IPRED predictions. Other models developed using clinical trial data may have been limited by inclusion/exclusion criteria and a less racially diverse population than this study's opportunistic dataset. The James model may represent a useful, but limited tool for model‐informed dosing of hospitalized children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
- Duke Clinical Research Institute, Durham, NC, USA.
- Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
- Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
- Critical Care Medicine, Nemours Children's Hospital, Delaware, Wilmington, DE, USA.
ORCID-Profile: Victória E Helfer, Stephen J Balevic
Förderung
- NICHD NIH HHS
- Pharmacokinetics/Pharmacodynamics Fellowship
- University of North Carolina
- GlaxoSmithKline
- National Institute of Child Health and Human Development
Zitieren
APA
McCann, S., Helfer, V. E., Balevic, S. J., Hornik, C. D., Goldstein, S. L., Autmizguine, J., Meyer, M., Al-Uzri, A., Anderson, S. G., Payne, E. H., Turdalieva, S., Gonzalez, D., & Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee (2024). Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2434
Vancouver
McCann S, Helfer VE, Balevic SJ, Hornik CD, Goldstein SL, Autmizguine J, et al. Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2434
BibTeX
@article{McCann2024,
author = {McCann, Sean and Helfer, Victória E and Balevic, Stephen J and Hornik, Chi D and Goldstein, Stuart L and Autmizguine, Julie and Meyer, Marisa and Al-Uzri, Amira and Anderson, Sarah G and Payne, Elizabeth H and Turdalieva, Sitora and Gonzalez, Daniel and Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee},
title = {Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants},
journal = {The Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1002/jcph.2434}
}
EUVIMED